AIHC Capital Management Ltd 13F holdings, Q4 2025
Holdings as of December 31, 2025 · filings on SEC EDGAR · latest filing →
AIHC Capital Management Ltd disclosed 6 US equity positions worth $106.7m in its Q4 2025 13F filing. The largest position was RVMD at 67.2% of the reported book, followed by PTGX and AVBP.
What did AIHC Capital Management Ltd own in Q4 2025? Top 6 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | RVMD REVOLUTION MEDICINES INC | Healthcare | 67.2% | $71.7m | 900,392 | – | |
| 2 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 15.5% | $16.6m | 189,823 | – | |
| 3 | AVBP ARRIVENT BIOPHARMA INC | 12.2% | $13.0m | 644,788 | – | ||
| 4 | COGT COGENT BIOSCIENCES INC | Healthcare | 3.3% | $3.6m | 100,000 | – | |
| 5 | NBP NOVABRIDGE BIOSCIENCES | Healthcare | 1.5% | $1.6m | 413,979 | – | |
| 6 | KRRO KORRO BIO INC | Healthcare | 0.2% | $242.4k | 30,265 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.